viernes, 11 de diciembre de 2015

Erratum: Vol. 64, No. 47

Erratum: Vol. 64, No. 47

MMWR Weekly
Vol. 64, No. 48
December 11, 2015
PDF of this issue

Erratum: Vol. 64, No. 47


December 11, 2015 / 64(48);1350

In the MMWR report, "Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases — United States, 2010–2015," multiple errors occurred. On page 1315, in the first paragraph of the report, the fifth, sixth, and seventh sentences should read, "The OXA-48 carbapenemase was first identified in Enterobacteriaceae in Turkey in 2001 (4), and OXA-48-like variants have subsequently been reported around the world. The first U.S. reports of OXA-48-like carbapenemases were published in 2013 and included retrospectively identified isolates from 2009 (5) and two isolates collected in 2012 from patients in Virginia who had recently been hospitalized outside the United States (6). Although there are limited additional published reports from the United States (7), CDC continues to receive reports of these organisms."
On page 1315, in the fourth paragraph of the report, the first and second sentences should read, "CRE producing OXA-48-like carbapenemases have demonstrated the ability to spread in other countries (8) and cause outbreaks in health care settings. Factors potentially contributing to the spread of these organisms include the high transfer efficiency of the plasmid containing OXA-48-like genes (8) and challenges in identifying these organisms."
On page 1316, the last sentence of the fourth paragraph should read, "The modification of the CDC CRE surveillance definition in January 2015 to include organisms that are resistant to ertapenem or that possess a carbapenemase gene should improve sensitivity for detecting OXA-48-producing CRE (9)."
On page 1316, the second sentence of the last paragraph of the report should read, "This is consistent with recommendations in the CDC Health Advisory from February 2013 (10), which sought to prevent transmission of isolates producing non-K. pneumoniae carbapenemases by improving their detection in patients recently hospitalized outside the United States."
On page 1316, reference 4 should read, "Liu Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. Epub Nov 18, 2015."

No hay comentarios:

Publicar un comentario